AZAFAROS
Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
AZAFAROS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2018-04-05
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.azafaros.com
Total Employee:
1+
Status:
Active
Contact:
+31 (0) 35 699 30 00
Email Addresses:
[email protected]
Total Funding:
27.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
BioGeneration Ventures
BioGeneration Ventures investment in Series A - Azafaros
Forbion Capital Partners
Forbion Capital Partners investment in Series A - Azafaros
BioMedPartners
BioMedPartners investment in Series A - Azafaros
BioGeneration Ventures
BioGeneration Ventures investment in Seed Round - Azafaros
Official Site Inspections
http://www.azafaros.com
- Host name: dedi8951.zxcs.nl
- IP address: 185.220.174.173
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
